A new trading day began on Friday, with Adma Biologics Inc (NASDAQ: ADMA) stock price up 18.76% from the previous day of trading, before settling in for the closing price of $16.31. ADMA’s price has ranged from $3.35 to $21.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 73.26% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 471.15%. With a float of $225.20 million, this company’s outstanding shares have now reached $226.06 million.
In an organization with 624 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 45.96%, operating margin of 25.42%, and the pretax margin is 11.86%.
Adma Biologics Inc (ADMA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adma Biologics Inc is 3.38%, while institutional ownership is 80.46%. The most recent insider transaction that took place on Sep 09 ’24, was worth 166,189. In this transaction Director of this company sold 9,000 shares at a rate of $18.47, taking the stock ownership to the 153,941 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Director proposed sale 9,000 for $16.26, making the entire transaction worth $146,340.
Adma Biologics Inc (ADMA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 471.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to 38.68% growth over the previous five years of trading.
Adma Biologics Inc (NASDAQ: ADMA) Trading Performance Indicators
Here are Adma Biologics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.24. Likewise, its price to free cash flow for the trailing twelve months is 80.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.14, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 0.66 in one year’s time.
Technical Analysis of Adma Biologics Inc (ADMA)
Let’s dig in a bit further. During the last 5-days, its volume was 4.41 million. That was better than the volume of 3.63 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 78.94%. Additionally, its Average True Range was 1.02.
During the past 100 days, Adma Biologics Inc’s (ADMA) raw stochastic average was set at 83.88%, which indicates a significant increase from 83.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.25% in the past 14 days, which was higher than the 72.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.87, while its 200-day Moving Average is $11.10. However, in the short run, Adma Biologics Inc’s stock first resistance to watch stands at $20.29. Second resistance stands at $21.20. The third major resistance level sits at $22.23. If the price goes on to break the first support level at $18.35, it is likely to go to the next support level at $17.32. The third support level lies at $16.41 if the price breaches the second support level.
Adma Biologics Inc (NASDAQ: ADMA) Key Stats
With a market capitalization of 5.36 billion, the company has a total of 233,083K Shares Outstanding. Currently, annual sales are 258,220 K while annual income is -28,240 K. The company’s previous quarter sales were 107,190 K while its latest quarter income was 32,060 K.
